My Quote Request
6505-01-318-1565
20 Products
ROBITUSSIN DM
DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP
NSN, MFG P/N
6505013181565
NSN
6505-01-318-1565
ROBITUSSIN DM
DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP
NSN, MFG P/N
6505013181565
NSN
6505-01-318-1565
MFG
ROBINS A H CO INC GOVERNMENT SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DEXTROMETHORPHAN HYDROBROMIDE PER 5 MILLILITERS AND 100.000 MILLIGRAMS GUAIFENESIN PER 5 MILLILITERS
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP 118ML BT
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONALCOHOLIC; TAMPER RESISTANT BT
Related Searches:
NDC00904-0053-20
DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP
NSN, MFG P/N
6505013181565
NSN
6505-01-318-1565
NDC00904-0053-20
DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP
NSN, MFG P/N
6505013181565
NSN
6505-01-318-1565
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DEXTROMETHORPHAN HYDROBROMIDE PER 5 MILLILITERS AND 100.000 MILLIGRAMS GUAIFENESIN PER 5 MILLILITERS
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP 118ML BT
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONALCOHOLIC; TAMPER RESISTANT BT
Related Searches:
NDC55370-0308-12
DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP
NSN, MFG P/N
6505013181565
NSN
6505-01-318-1565
NDC55370-0308-12
DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP
NSN, MFG P/N
6505013181565
NSN
6505-01-318-1565
MFG
MOVA PHARMACEUTICAL CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DEXTROMETHORPHAN HYDROBROMIDE PER 5 MILLILITERS AND 100.000 MILLIGRAMS GUAIFENESIN PER 5 MILLILITERS
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP 118ML BT
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONALCOHOLIC; TAMPER RESISTANT BT
Related Searches:
NDC55532-0600-08
DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP
NSN, MFG P/N
6505013181866
NSN
6505-01-318-1866
NDC55532-0600-08
DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN SYRUP
NSN, MFG P/N
6505013181866
NSN
6505-01-318-1866
MFG
ION LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DEXTROMETHORPHAN HYDROBROMIDE ACTIVE INGREDIENT AND 100.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALCOHOL FREE; SUGARLESS
Related Searches:
6984-46
SKIN PROTECTIVE OINTMENT,MOISTURE BARRIER
NSN, MFG P/N
6505013181867
NSN
6505-01-318-1867
6984-46
SKIN PROTECTIVE OINTMENT,MOISTURE BARRIER
NSN, MFG P/N
6505013181867
NSN
6505-01-318-1867
MFG
CONVATEC A BRISTOL-MYERS SQUIBB CO
Description
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: CONTAINS WHITE PETROLATUM,ALOE VERA GEL,AND EMOLLIENTS
Related Searches:
NDC00024-1414-03
IOHEXOL INJECTION
NSN, MFG P/N
6505013182947
NSN
6505-01-318-2947
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS IODINE EQUIVALENT PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 150 ML. IN A 200 ML. VIAL; PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
OMNIPAQUE 350
IOHEXOL INJECTION
NSN, MFG P/N
6505013182947
NSN
6505-01-318-2947
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS IODINE EQUIVALENT PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 150 ML. IN A 200 ML. VIAL; PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
LIPOSYN II
FAT EMULSION INJECTION
NSN, MFG P/N
6505013185720
NSN
6505-01-318-5720
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V SAFFLOWER OIL ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PERCENTAGE W/V EGG PHOSPHATIDES ACTIVE INGREDIENT AND 2.500 PERCENTAGE W/V GLYCERIN IN WATER FOR INJECTION ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FAT EMULSION INJECTION 500ML BOTTLE 12S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
LIPOSYN II 20%
FAT EMULSION INJECTION
NSN, MFG P/N
6505013185720
NSN
6505-01-318-5720
LIPOSYN II 20%
FAT EMULSION INJECTION
NSN, MFG P/N
6505013185720
NSN
6505-01-318-5720
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V SAFFLOWER OIL ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PERCENTAGE W/V EGG PHOSPHATIDES ACTIVE INGREDIENT AND 2.500 PERCENTAGE W/V GLYCERIN IN WATER FOR INJECTION ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FAT EMULSION INJECTION 500ML BOTTLE 12S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00074-9789-03
FAT EMULSION INJECTION
NSN, MFG P/N
6505013185720
NSN
6505-01-318-5720
NDC00074-9789-03
FAT EMULSION INJECTION
NSN, MFG P/N
6505013185720
NSN
6505-01-318-5720
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V SAFFLOWER OIL ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PERCENTAGE W/V EGG PHOSPHATIDES ACTIVE INGREDIENT AND 2.500 PERCENTAGE W/V GLYCERIN IN WATER FOR INJECTION ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FAT EMULSION INJECTION 500ML BOTTLE 12S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
K-DUR
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505013185737
NSN
6505-01-318-5737
K-DUR
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505013185737
NSN
6505-01-318-5737
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 1500MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
NDC00085-0787-06
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505013185737
NSN
6505-01-318-5737
NDC00085-0787-06
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505013185737
NSN
6505-01-318-5737
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 1500MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
ANAFRANIL
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
ANAFRANIL
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE CAPSULES 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ANAFRANIL CAPSULES
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
ANAFRANIL CAPSULES
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE CAPSULES 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00093-0956-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
NDC00093-0956-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE CAPSULES 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-3025-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
NDC00378-3025-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE CAPSULES 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-2027-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
NDC00781-2027-01
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
MFG
GENEVA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE CAPSULES 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC58887-0115-30
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
NDC58887-0115-30
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187398
NSN
6505-01-318-7398
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE CAPSULES 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ANAFRANIL
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187399
NSN
6505-01-318-7399
ANAFRANIL
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187399
NSN
6505-01-318-7399
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 25MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 CAPSULES PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
ANAFRANIL CAPSULES
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187399
NSN
6505-01-318-7399
ANAFRANIL CAPSULES
CLOMIPRAMINE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505013187399
NSN
6505-01-318-7399
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CLOMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOMIPRAMINE HYDROCHLORIDE CAPSULES 25MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 CAPSULES PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 1